OQROGet OQRO Pro
Insider trade

Neumora Therapeutics (NMRA)See Remarks sold ~$83K

Daljit Singh Aurora, See Remarks at Neumora Therapeutics, sold ~$83K of Neumora Therapeutics shares.

~$83K
Approx. value · 55K sh @ $1.50
Traded
Aug 17, 2026
Filed
Aug 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 14, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On August 14, 2026, the Company announced that Paul L. Berns, the Company’s current Chief Executive Officer, will become the Company’s Executive Chairperson of the Board of Directors (the “Board”), and Joshua Pinto, Ph.D., the Company’s current President, will succeed Mr. Berns as the Company’s Chief Executive Officer (the “Leadership Transition”) effective August 14, 2026 (the “Transition Date”).”
  2. Aug 17, 2026 · this disclosureInsiderOfficer sold ~$83K of NMRA shares in the open market

What came next

  1. Aug 17, 2026Insider · 1 personInsiders: 2 sales (~$137K)
  2. Aug 18, 2026Insider · 1 personInsiders: 2 sales (~$110K)
  3. Aug 19, 2026Insider · 1 personInsiders: 2 sales (~$102K)
  4. Aug 20, 2026Insider · 1 personInsiders: 2 sales (~$204K)
  5. Aug 21, 2026Insider · 1 personInsiders: 2 sales (~$66K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neumora Therapeutics

For Neumora Therapeutics, OQRO holds 11 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NMRA page.

Other recent filings by Daljit Singh Aurora, See Remarks

The full history of Daljit Singh Aurora, See Remarks is on the profile page.

How this filing works

Other disclosures at Neumora Therapeutics

Everything OQRO holds on this company is on its NMRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data